Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
Stephanie A. Wisner
Stephanie A. Wisner co-founded the biotech start-up, Centivax, where she is now Chief Business Officer. She has also advised multiple biotech start-ups on business and commercialization strategy through her consulting business, BioVenture Advising LLC. In 2022, she was named to the Forbes 30 Under 30 list for Healthcare. Her first book, Building Backwards to Biotech, was published in 2022 and was a #1 best seller on Amazon in Biotechnology. She completed her MBA at the University of Chicago Booth School of Business, with concentrations in finance, accounting, and entrepreneurship. She received her Bachelor’s Degree in chemistry and chemical biology from Cornell University and was awarded the Einhorn Discovery Research Grant for her independent research on cancer. While she no longer gets as much time in the lab, she enjoys the travel and continuous learning this career involves.
In this episode of the Life Science Success podcast I interviewed Stephanie Wisner. We discussed Co-Founding Centivax and her new book Building Backwards to Biotech: the Power of Entrepreneurship to Drive Cutting-Edge Science to Market.